CIA
LLY icon

Compass Ion Advisors’s Eli Lilly LLY Stock Holding History

Compass Ion Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.56M Buy
2,130
+9
+0.4% +$9.2K 0.22% 56
2026
Q1 		$1.95M Buy
2,121
+48
+2% +$48.7K 0.19% 68
2025
Q4 		$2.23M Sell
2,073
-92
-4% -$88K 0.21% 57
2025
Q3 		$1.65M Buy
2,165
+86
+4% +$64K 0.16% 73
2025
Q2 		$1.62M Sell
2,079
-291
-12% -$226K 0.18% 68
2025
Q1 		$1.96M Buy
2,370
+18
+0.8% +$15K 0.23% 53
2024
Q4 		$1.82M Sell
2,352
-4
-0.2% -$3.31K 0.22% 60
2024
Q3 		$2.09M Buy
2,356
+16
+0.7% +$14.4K 0.26% 55
2024
Q2 		$1.82M Hold
2,340
– – 0.26% 54
2024
Q1 		$1.82M Buy
2,340
+117
+5% +$83.3K 0.26% 55
2023
Q4 		$1.3M Buy
2,223
+598
+37% +$349K 0.2% 72
2023
Q3 		$873K Buy
+1,625
New +$837K 0.15% 97

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Compass Ion Advisors's LLY Position: Q2 2026 in Review

Compass Ion Advisors increased its Eli Lilly (LLY) stake by 0.42% in Q2 2026, buying an estimated $9.2K and bringing the position to 2,130 shares worth $2.56M. The position accounts for 0.22% of the portfolio, ranked #56.

Compass Ion Advisors first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Compass Ion Advisors held 2,130 shares of Eli Lilly worth $2.56M as of Q2 2026.
  • Compass Ion Advisors bought 9 Eli Lilly shares in Q2 2026, an estimated $9.2K.
  • Eli Lilly made up 0.22% of Compass Ion Advisors's portfolio in Q2 2026, its #56 holding.
  • Compass Ion Advisors first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Compass Ion Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.